EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Telomere Length as a New Risk Marker of Early-Onset Colorectal Cancer

Abel Martel-Martel iD, Luis A Corchete iD, Marc Martí iD, Rosario Vidal-Tocino iD, Elena Hurtado, Edurne Álvaro, Fernando Jiménez, Marta Jiménez-Toscano, Francesc Balaguer iD, Gonzalo Sanz, Irene López, Sergio Hernández-Villafranca und 9 weitere

International Journal of Molecular Sciences · 09.02.2023 · 24 (4) · 3526

DOI: 10.3390/ijms24043526 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 09.02.2023. Verfasst von Abel Martel-Martel und 20 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedical Research of Salamanca (IBSAL-SACYL), University of Salamanca-CSIC, Paseo de San Vicente, 58-182, 37007 Salamanca, Spain. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Telomere, Early Detection of Cancer. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, European Union, Dr. Moraza Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Early-onset colorectal cancer (EOCRC; age younger than 50 years) incidence has been steadily increasing in recent decades worldwide. The need for new biomarkers for EOCRC prevention strategies is undeniable. In this study, we aimed to explore whether an aging factor, such as telomere length (TL), could be a useful tool in EOCRC screening. The absolute leukocyte TL from 87 microsatellite stable EOCRC patients and 109 healthy controls (HC) with the same range of age, was quantified by Real Time Quantitative PCR (RT-qPCR). Then, leukocyte whole-exome sequencing (WES) was performed to study the status of the genes involved in TL maintenance (hTERT, TERC, DKC1, TERF1, TERF2, TERF2IP, TINF2, ACD, and POT1) in 70 sporadic EOCRC cases from the original cohort. We observed that TL was significantly shorter in EOCRC patients than in healthy individuals (EOCRC mean: 122 kb vs. HC mean: 296 kb; p < 0.001), suggesting that telomeric shortening could be associated with EOCRC susceptibility. In addition, we found a significant association between several SNPs of hTERT (rs79662648), POT1 (rs76436625, rs10263573, rs3815221, rs7794637, rs7784168, rs4383910, and rs7782354), TERF2 (rs251796 and rs344152214), and TERF2IP (rs7205764) genes and the risk of developing EOCRC. We consider that the measurement of germline TL and the status analysis of telomere maintenance related genes polymorphisms at early ages could be non-invasive methods that could facilitate the early identification of individuals at risk of developing EOCRC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsTelomereEarly Detection of CancerHumansMiddle AgedIncidenceBiomarkers, TumorNuclear ProteinsCell Cycle Proteins

Stichwörter der Autor:innen

colorectal cancerearly-onset colorectal cancerriskscreeningtelomere length

Substanzen

Biomarkers, TumorDKC1 protein, humanNuclear ProteinsCell Cycle Proteins

Autor:innen und Institutionen

  • Institute of Biomedical Research of Salamanca (IBSAL-SACYL), University of Salamanca-CSIC, Paseo de San Vicente, 58-182, 37007 Salamanca, Spain.
  • Molecular Medicine Unit, Department of Medicine, University of Salamanca, 37007 Salamanca, Spain.
  • Institute of Molecular and Cellular Biology of Cancer (IBMCC), University of Salamanca-CSIC, 37007 Salamanca, Spain.
  • Department of Surgery, Vall d'Hebron University Hospital, 08035 Barcelona, Spain.
  • Medical Oncology Department, Hospital Universitario de Salamanca, 37007 Salamanca, Spain.
  • Department of Surgery, Hospital Universitario Gregorio Marañón, 28007 Madrid, Spain.

ORCID-Profile: Abel Martel-Martel, Luis A Corchete, Marc Martí, Rosario Vidal-Tocino, Francesc Balaguer, Araceli Ballestero, Carlos Pastor, Manuel A Gómez-Marcos, Juan J Cruz-Hernández, José Perea, Rogelio González-Sarmiento

Förderung

  • Instituto de Salud Carlos III
  • European Union
  • Dr. Moraza Foundation

Zitieren

APA

Martel-Martel, A., Corchete, L. A., Martí, M., Vidal-Tocino, R., Hurtado, E., Álvaro, E., Jiménez, F., Jiménez-Toscano, M., Balaguer, F., Sanz, G., López, I., Hernández-Villafranca, S., Ballestero, A., Vivas, A., Melone, S., Pastor, C., Brandáriz, L., Gómez-Marcos, M. A., Cruz-Hernández, J. J., …, & González-Sarmiento, R. (2023). Telomere Length as a New Risk Marker of Early-Onset Colorectal Cancer. International Journal of Molecular Sciences, 24(4), 3526. https://doi.org/10.3390/ijms24043526

Vancouver

Martel-Martel A, Corchete LA, Martí M, Vidal-Tocino R, Hurtado E, Álvaro E, et al. Telomere Length as a New Risk Marker of Early-Onset Colorectal Cancer. International Journal of Molecular Sciences. 2023;24(4):3526. doi:10.3390/ijms24043526

BibTeX
@article{MartelMartel2023,
  author = {Martel-Martel, Abel and Corchete, Luis A and Martí, Marc and Vidal-Tocino, Rosario and Hurtado, Elena and Álvaro, Edurne and Jiménez, Fernando and Jiménez-Toscano, Marta and Balaguer, Francesc and Sanz, Gonzalo and López, Irene and Hernández-Villafranca, Sergio and Ballestero, Araceli and Vivas, Alfredo and Melone, Sirio and Pastor, Carlos and Brandáriz, Lorena and Gómez-Marcos, Manuel A and Cruz-Hernández, Juan J and Perea, José and González-Sarmiento, Rogelio},
  title = {Telomere Length as a New Risk Marker of Early-Onset Colorectal Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {4},
  pages = {3526},
  doi = {10.3390/ijms24043526}
}
Kostenlos starten →